Nvidia rose after its $2 billion Marvell deal reinforced demand across AI infrastructure, with investors watching whether similar partnerships continue to drive gains after the recent pullback.
Nvidia rose after its $2 billion Marvell deal reinforced demand across AI infrastructure, with investors watching whether similar partnerships continue to drive gains after the recent pullback.
Nvidia (NASDAQ:NVDA), a leader in GPUs and AI computing platforms, closed Tuesday at $174.40, up 5.59%. The stock moved higher after news of a $2 billion Marvell Technology investment and expanded AI infrastructure partnership, which investors are viewing as a fresh AI demand cat
Nvidia (NASDAQ:NVDA), a leader in GPUs and AI computing platforms, closed Tuesday at $174.40, up 5.59%. The stock moved higher after news of a $2 billion Marvell Technology investment and expanded AI infrastructure partnership, which investors are viewing as a fresh AI demand cat
Earnings Call Insights: J.Jill, Inc. (JILL) Q4 2025 Management view CEO Mary Coyne framed 2025 as “the beginning of a strategic evolution,” saying the company is using “testing and learning” to expand its customer file through “product evolution, enhancing the customer journey and improving the way we work as an organization.” She said Q4 “reinforced why this evolution is essential,” citing “an ea...
Earnings Call Insights: J.Jill, Inc. (JILL) Q4 2025 Management view CEO Mary Coyne framed 2025 as “the beginning of a strategic evolution,” saying the company is using “testing and learning” to expand its customer file through “product evolution, enhancing the customer journey and improving the way we work as an organization.” She said Q4 “reinforced why this evolution is essential,” citing “an early assortment that did not resonate as hoped,” “earlier and deeper competitive holiday promotions,” and a direct customer “migrat[ing] towards the promotional end of the spectrum.” Coyne said the 2026 plan centers on broadening appeal while retaining core attributes: “We’re expanding into new categories and modernizing our aesthetic to appeal to a broader customer base. But doing so in a way that upholds the quality, fit and values that our loyal customers expect.” She added, “This evolution will take time, and we should not expect the path to be linear.” Coyne highlighted leadership additions: “We brought Courtney O’Connor on board in July as Chief Merchandising Officer” and “Viv Rettke in November as the company’s first-ever Chief Growth Officer to lead our e-commerce and AI initiatives.” On product, Coyne pointed to Q4 tests and a more visible shift in 2026: “Our summer 2026 assortment, which will be introduced in Q2, will capture the first influence from our strengthened merchant and design team,” including “more newness with silhouettes and fabrics” and “the beginning stages of expansion into areas of accessories such as bags and belts.” Webb positioned FY2026 as an “investment and measured transition,” saying, “This requires deliberate investments that will pressure near-term profitability, but position us for stronger performance in 2027 and beyond.” He added, “Our strong balance sheet and cash position provide flexibility to execute this strategic evolution while continuing to return capital to shareholders.” Outlook Management did not provide EPS guidance in the t...
Defence ministry says contact was lost with the An-26 military transport aircraft whilst it was on a scheduled flight over the Crimean Peninsula A Russian Antonov-26 military plane crashed while flying over the Crimean peninsula, killing 29 people, the TASS news agency reported Wednesday, quoting Russia’s defence ministry. “On 31 March at around 18:00 Moscow time, contact was lost with the An-26 m...
Defence ministry says contact was lost with the An-26 military transport aircraft whilst it was on a scheduled flight over the Crimean Peninsula A Russian Antonov-26 military plane crashed while flying over the Crimean peninsula, killing 29 people, the TASS news agency reported Wednesday, quoting Russia’s defence ministry. “On 31 March at around 18:00 Moscow time, contact was lost with the An-26 military transport aircraft whilst it was on a scheduled flight over the Crimean Peninsula,” the defence ministry said. Continue reading...
Sadie Sink and Noah Jupe’s pure chemistry perfectly encapsulates the urgent and uncompromising nature of first love Has the conveyor belt from screen-to-stage celebrity turned full circle when a star from a hit TV series steps on to the West End stage in a production that is running contemporaneously with a stage adaptation of that same TV series? Sadie Sink, better known to Stranger Things fans a...
Sadie Sink and Noah Jupe’s pure chemistry perfectly encapsulates the urgent and uncompromising nature of first love Has the conveyor belt from screen-to-stage celebrity turned full circle when a star from a hit TV series steps on to the West End stage in a production that is running contemporaneously with a stage adaptation of that same TV series? Sadie Sink, better known to Stranger Things fans as Max Mayfield, performed her West End debut while Stranger Things: First Shadow played up the road, at the Phoenix theatre, in a prequel to the Duffer Brothers’ series. It may seem like the Netflixification of the West End, but Sink actually began life as a theatre actor – and earned a Tony nomination for Broadway’s run of John Proctor is a Villain , currently at the Royal Court for its London run . At the Harold Pinter theatre, London, until 20 June. Continue reading...
Andrii Dodonov/iStock via Getty Images TG Therapeutics' ( TGTX ) multiple sclerosis (MS) drug, Briumvi, appears on the way to blockbuster status with net revenues nearing $600M in 2025, just three years into its launch. I rated TGTX a buy in November 2025, noting clinical work with Briumvi now could help drive revenue growth in the future, and a media campaign could deliver revenue growth near-ter...
Andrii Dodonov/iStock via Getty Images TG Therapeutics' ( TGTX ) multiple sclerosis (MS) drug, Briumvi, appears on the way to blockbuster status with net revenues nearing $600M in 2025, just three years into its launch. I rated TGTX a buy in November 2025, noting clinical work with Briumvi now could help drive revenue growth in the future, and a media campaign could deliver revenue growth near-term. This article looks at the performance of Briumvi since that article, updates from the company's clinical work, and the company's financials. With commercial performance remaining strong, a catalyst near-term with results from the ENHANCE trial and stock buybacks helping to support the stock, I again rate TGTX a buy. Briumvi Growth Isn't Petering Out Despite my buy rating on TGTX in November, in August, following Q2'25 earnings, I noted percentage growth in each subsequent quarter of sales of Briumvi appeared to be slowing. Of course a drug can't keep up the 100% or 50% quarterly increases in growth that are seen earlier in launch, but I did want to keep an eye on whether the rate of growth from one quarter to the next would continue to slip, perhaps below 10%. Such a scenario would put more pressure on things like subcutaneous (SC) Briumvi or treatment of new diseases altogether to drive revenues of Briumvi markedly higher. Q4'25 earnings, however, have come with US net product revenues of $182.7M, a 19.5% increase from the $152.9M reported in Q3'25 . Table 1: US Briumvi net product revenues by quarter. Table by Biotech Beast; numbers from company press releases and quarterly filings. US Briumvi net product revenue ($M) Growth Over Prior Quarter Q1'23 7.8 - Q2'23 16 105% Q3'23 25.1 57% Q4'23 39.9 59% Q1'24 50.5 27% Q2'24 72.6 44% Q3'24 83.3 15% Q4'24 103.6 24% Q1'25 119.7 16% Q2'25 138.8 16% Q3'25 152.9 10% Q4'25 182.7 19% Click to enlarge It appears growth of IV Briumvi is not petering out just yet, potentially aided by certain marketing efforts, such as direct-to-consu...
Duos Technologies Group (NASDAQ:DUOT) executives used the company’s fourth-quarter and full-year 2025 earnings call to outline a strategic shift toward data centers, including plans to divest its legacy rail business and expand newer data center infrastructure and sourcing operations. Strategic shi
Duos Technologies Group (NASDAQ:DUOT) executives used the company’s fourth-quarter and full-year 2025 earnings call to outline a strategic shift toward data centers, including plans to divest its legacy rail business and expand newer data center infrastructure and sourcing operations. Strategic shi
CALGARY, Alberta, March 31, 2026 (GLOBE NEWSWIRE) -- Prairie Provident Resources Inc. ("Prairie Provident" or the "Company") (TSX:PPR) announces its financial and operating results for the fourth quarter and year ended December 31, 2025, along with its year-end reserves. Prairie Provident's audited annual consolidated financial statements and related Management's Discussion and Analysis ("MD&A") f...
CALGARY, Alberta, March 31, 2026 (GLOBE NEWSWIRE) -- Prairie Provident Resources Inc. ("Prairie Provident" or the "Company") (TSX:PPR) announces its financial and operating results for the fourth quarter and year ended December 31, 2025, along with its year-end reserves. Prairie Provident's audited annual consolidated financial statements and related Management's Discussion and Analysis ("MD&A") for the year ended December 31, 2025, and Annual Information Form dated March 31, 2026 containing year-end reserves data and other information for the period, are available on the Company's website at www.ppr.ca and filed on SEDAR+ at www.sedarplus.ca .
Last-day gains didn’t stop the S&P 500 from tallying its worst first quarter since 2022 as the Iran conflict, private-credit worries and the AI ‘scare trade’ weighed on stocks in March.
Last-day gains didn’t stop the S&P 500 from tallying its worst first quarter since 2022 as the Iran conflict, private-credit worries and the AI ‘scare trade’ weighed on stocks in March.
TEHRAN, IRAN - MARCH 02: A general view of Tehran with smoke visible in the distance after explosions were reported in the city, on March 02, 2026 in Tehran, Iran. (Photo by Contributor/Getty Images)
TEHRAN, IRAN - MARCH 02: A general view of Tehran with smoke visible in the distance after explosions were reported in the city, on March 02, 2026 in Tehran, Iran. (Photo by Contributor/Getty Images)